Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v1-EN
Language English English
Date Updated 2017-04-27 2017-03-14
Drug Identification Number 02300206 00001686
Brand name SEROQUEL XR XYLOCAINE VISCOUS 2%
Common or Proper name quetiapine fumarate extended-release tablets lidocaine hydrochloride solution
Company Name ASTRAZENECA CANADA INC ASPEN PHARMACARE CANADA INC.
Ingredients QUETIAPINE LIDOCAINE HYDROCHLORIDE
Strength(s) 300MG 20MG
Dosage form(s) TABLET (EXTENDED-RELEASE) LIQUID
Route of administration ORAL ORAL TOPICAL
Packaging size 60 tablets 100 mL
ATC code N05AH N01BB
ATC description ANTIPSYCHOTICS ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug. Shortage of an inactive ingredient or component.
Anticipated start date 2017-04-24 2017-03-14
Actual start date 2017-04-24
Estimated end date 2017-04-26 Unknown
Actual end date 2017-04-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments